Product
Paromomycin
2 clinical trials
1 indication
Indication
Visceral LeishmaniasisClinical trial
An Open Label, Phase III, Randomized Controlled, Multicentre Non-Inferiority Trial to Compare Efficacy and Safety of Miltefosine and Paromomycin With SSG and PM Combination for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern AfricaStatus: Completed, Estimated PCD: 2020-12-11
Clinical trial
A Randomized, Open-label, Phase II, Single-centre Study to Evaluate the Efficacy, Safety and Pharmacokinetics of LXE408 in Patients With Primary Visceral Leishmaniasis in EthiopiaStatus: Recruiting, Estimated PCD: 2025-06-30